KEY FEATURES
| Full Name | Chemokine C-X-C-Motif Ligand 3 |
|---|---|
| Synonym | GROg; SCYB3; GRO3; GRO-G; MIP2-B; MIP2b; CINC2b; CINC2b; Growth Regulated Oncogene Gamma; Macrophage inflammatory protein 2-beta |
| Assay Type | Sandwich |
| Reactivity | Rat |
| Range | 15.62-1000pg/mL |
| Sensitivity | 5.8pg/mL |
| Sample Type | Serum,plasma and other biological fluids |
| Sample Volume | 100μL |
| Detection Wavelength | OD450 |
| Transportation Temperature | 2-8°C |
| Specificity | The kit detected Rat CXCL3 in the samples and no significant cross-species reactions were found |
| Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
| This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Rat CXCL3. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Rat CXCL3 and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Rat CXCL3, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Rat CXCL3. You can calculate the concentration of Rat CXCL3 in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
| Components | Specifications | Storage and Notes |
|---|---|---|
| Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
| Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
| Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
| HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
| Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
| Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
| Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
| Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Rat CXCL3 ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
| Intra-assay Precision | Inter-assay Precision | |||||
|---|---|---|---|---|---|---|
| Sample | 1 | 2 | 3 | 1 | 2 | 3 |
| n | 20 | 20 | 20 | 20 | 20 | 20 |
| Mean (pg/mL) | 50.91 | 113.56 | 454.78 | 54.03 | 112.84 | 435.25 |
| Standard deviation | 3.54 | 6.65 | 24.51 | 3.56 | 4.82 | 16.23 |
| CV(%) | 6.95 | 5.86 | 5.39 | 6.58 | 4.27 | 3.73 |
RECOVERY
The recovery of Rat CXCL3 spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
| Sample Type | Range (%) | Average Recovery (%) |
|---|---|---|
| Serum(n=8) | 94-106 | 100 |
| EDTA plasma (n=8) | 87-99 | 92 |
| Cell culture media (n=8) | 91-105 | 97 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Rat CXCL3 in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with GROg ELISA Kits
| Cxcl2 ELISA Kit | publications with GROg and Cxcl2 |
| Cxcl5 ELISA Kit | publications with GROg and Cxcl5 |
| Ccl20 ELISA Kit | publications with GROg and Ccl20 |
| Ccl5 ELISA Kit | publications with GROg and Ccl5 |
| Cxcl10 ELISA Kit | publications with GROg and Cxcl10 |
| Cxcr2 ELISA Kit | publications with GROg and Cxcr2 |
| Cxcl11 ELISA Kit | publications with GROg and Cxcl11 |
| Cxcl12 ELISA Kit | publications with GROg and Cxcl12 |
| Cxcr3 ELISA Kit | publications with GROg and Cxcr3 |
| Ccr1 ELISA Kit | publications with GROg and Ccr1 |
Pathways associated with GROg ELISA Kit
| Chemokine Receptors Bind Chemokines Pathway | Chemokine Receptors Bind Chemokines Pathway |
| Chemokine Signaling Pathway | Chemokine Signaling Pathway |
| Class A/1 (Rhodopsin-like Receptors) Pathway | Class A/1 (Rhodopsin-like Receptors) Pathway |
| Cytokines And Inflammatory Response (BioCarta) Pathway | Cytokines And Inflammatory Response (BioCarta) Pathway |
| G Alpha (i) Signalling Events Pathway | G Alpha (i) Signalling Events Pathway |
| GPCR Downstream Signaling Pathway | GPCR Downstream Signaling Pathway |
| GPCR Ligand Binding Pathway | GPCR Ligand Binding Pathway |
| Immune System Pathway | Immune System Pathway |
| Innate Immune System Pathway | Innate Immune System Pathway |
Diseases associated with GROg ELISA Kit
| Inflammation | publications with GROg and Inflammation |
| Necrosis | publications with GROg and Necrosis |
| Lung Diseases | publications with GROg and Lung Diseases |
| Skin Diseases | publications with GROg and Skin Diseases |
| Disease Models, Animal | publications with GROg and Disease Models, Animal |
| Death | publications with GROg and Death |
| Fibrosis | publications with GROg and Fibrosis |
| Neoplasms, Experimental | publications with GROg and Neoplasms, Experimental |
| Lung Neoplasms | publications with GROg and Lung Neoplasms |
| Heart Diseases | publications with GROg and Heart Diseases |
Organs/Tissues associated with GROg ELISA Kit
| Lung | publications with GROg and Lung |
| Eye | publications with GROg and Eye |
| Connective Tissue | publications with GROg and Connective Tissue |